Search

everythinglearnresearchcommunity

for

Search:↓

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Male hormones worsen kidney transplant damage, but blocking them helps.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Some supplements and hormones can increase hair loss by raising DHT levels.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Minoxidil stimulates hair growth by increasing hair thickness and prolonging growth phase.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.